Found: 15
Select item for more details and to access through your institution.
Cancer cell migration on elongate protrusions of fibroblasts in collagen matrix.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-36646-z
- By:
- Publication type:
- Article
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10467-w
- By:
- Publication type:
- Article
Modulation of matrix metalloproteinase-9 secretion from tumor-associated macrophage-like cells by proteolytically processed laminin-332 (laminin-5).
- Published in:
- Clinical & Experimental Metastasis, 2014, v. 31, n. 3, p. 285, doi. 10.1007/s10585-013-9627-0
- By:
- Publication type:
- Article
Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e679, doi. 10.1634/theoncologist.2019-0299
- By:
- Publication type:
- Article
Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. e833, doi. 10.1016/j.cllc.2021.04.007
- By:
- Publication type:
- Article
Epithelial-Mesenchymal Transition Stimulates Human Cancer Cells to Extend Microtubule-based Invasive Protrusions and Suppresses Cell Growth in Collagen Gel.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0053209
- By:
- Publication type:
- Article
Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83609-y
- By:
- Publication type:
- Article
Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 9, p. 2109, doi. 10.1007/s00262-022-03141-4
- By:
- Publication type:
- Article
Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2290, doi. 10.3390/cancers13102290
- By:
- Publication type:
- Article
Expression of laminin γ2 chain monomer enhances invasive growth of human carcinoma cells in vivo.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 9, p. 2031, doi. 10.1002/ijc.25231
- By:
- Publication type:
- Article
CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 72, doi. 10.1111/cas.14705
- By:
- Publication type:
- Article
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients with EGFR‐mutant non‐small cell lung cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 10, p. 3244, doi. 10.1111/cas.14156
- By:
- Publication type:
- Article
IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 4, p. 1293, doi. 10.1111/cas.13964
- By:
- Publication type:
- Article
Highly sensitive detection of invasive lung cancer cells by novel antibody against amino-terminal domain of laminin γ2 chain.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1909, doi. 10.1111/cas.13089
- By:
- Publication type:
- Article
Amino-terminal fragments of laminin γ2 chain retract vascular endothelial cells and increase vascular permeability.
- Published in:
- Cancer Science, 2014, v. 105, n. 2, p. 168, doi. 10.1111/cas.12323
- By:
- Publication type:
- Article